Tech Company Financing Transactions

DermBiont Funding Round

On 10/24/2023, DermBiont announced $35.2 million in Series B funding from Double Point Ventures, private investors and Viking Global Investors.

Transaction Overview

Company Name
Announced On
10/24/2023
Transaction Type
Venture Equity
Amount
$35,200,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to advance two drugs in development, SM-020, a topical novel AKT kinase inhibitor for the treatment of seborrheic keratoses (SKs), and SM-030, a topical novel PKC-beta inhibitor for the treatment of melasma and other hyperpigmentation disorders of the skin.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75 Kneeland St. 14th Floor
Boston, MA 02118
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
DermBiont develops skin microbiome therapeutics platform to treat and prevent skin diseases. DermBiont is at the intersection of two highly active sectors: dermatology and the microbiome. They harness naturally occurring microbes on the human skin that have evolved over hundreds of thousands of years to compete with pathogenic microbes.
Profile
DermBiont LinkedIn Company Profile
Social Media
DermBiont Company Twitter Account
Company News
DermBiont News
Facebook
DermBiont on Facebook
YouTube
DermBiont on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Karl Beutner
  Karl Beutner LinkedIn Profile  Karl Beutner Twitter Account  Karl Beutner News  Karl Beutner on Facebook
Chief Financial Officer
Max Dawson
  Max Dawson LinkedIn Profile  Max Dawson Twitter Account  Max Dawson News  Max Dawson on Facebook
Chief Medical Officer
Shilpa Goel
  Shilpa Goel LinkedIn Profile  Shilpa Goel Twitter Account  Shilpa Goel News  Shilpa Goel on Facebook
Chief Scientific Officer
Robert Brucker
  Robert Brucker LinkedIn Profile  Robert Brucker Twitter Account  Robert Brucker News  Robert Brucker on Facebook
VP - Bus. Development
Nick Eliovits
  Nick Eliovits LinkedIn Profile  Nick Eliovits Twitter Account  Nick Eliovits News  Nick Eliovits on Facebook
VP - Operations
Sanjay Jain
  Sanjay Jain LinkedIn Profile  Sanjay Jain Twitter Account  Sanjay Jain News  Sanjay Jain on Facebook
VP - Operations
Deryck Wade
  Deryck Wade LinkedIn Profile  Deryck Wade Twitter Account  Deryck Wade News  Deryck Wade on Facebook
VP - R & D
Xuecheng Zhang
  Xuecheng Zhang LinkedIn Profile  Xuecheng Zhang Twitter Account  Xuecheng Zhang News  Xuecheng Zhang on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/24/2023: Qosmosys venture capital transaction
Next: 10/24/2023: Aleph venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to record tech company VC transactions. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary